Characterization of natural vasostatin-containing peptides in rat heart

FEBS Journal

Volumn 273, Issue 14, 2006, Pages 3311-3321

  Glattard, Elise ^a   Angelone, Tommaso ^b   Strub, Jean Marc ^c   Corti, Angelo ^d   Aunis, Dominique ^a   Tota, Bruno ^b   Metz Boutigue, Marie Hélène ^a   Goumon, Yannick ^a  

^a INSERM   (France)

^b UNIVERSITY OF CALABRIA   (Italy)

^c CNRS   (France)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chromogranin A; Heart; Post translational modifications; Rat; Vasostatin

Indexed keywords

CHROMOGRANIN A; METHIONINE; STATIN; TRISACCHARIDE; UNCLASSIFIED DRUG; VASOSTATIN;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; GLYCOSYLATION; HEART MUSCLE CELL; IMMUNOREACTIVITY; MALE; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PARACRINE SIGNALING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTEIN PROCESSING; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING;

ADRENAL GLANDS; AMINO ACID SEQUENCE; ANIMALS; CALRETICULIN; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOGRANIN A; CHROMOGRANINS; CONSERVED SEQUENCE; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MYOCARDIUM; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

ANURA;

EID: 33745605840     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05334.x     Document Type: Article

References (67)

1. Helle KB (1968) The chromogranin of the adrenal medulla: a high-density lipoprotein. Biochem J 109, 43P-44P.
2. Simon JP & Aunis D (1989) Biochemistry of the chromogranin A protein family. Biochem J 262, 1-13.
3. Iacangelo A, Okayama H & Eiden LE (1988) Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Lett 227, 115-121.
4. Aunis D (1998) Exocytosis in chromaffin cells of the adrenal medulla. Int Rev Cytol 181, 213-320.
5. Aunis D & Metz-Boutigue MH (2000) Chromogranins: current concepts. Structural and functional aspects. Adv Exp Med Biol 482, 21-38.
6. Winkler H & Fischer-Colbrie R (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49, 497-528.
7. Helle KB (2004) The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 79, 769-794.
8. Kieker S, Fischer-Colbrie R, Eiden L & Winkler H (1988) Phylogenetic distribution of peptides related to chromogranins A and B. J Neurochem 50, 1066-1073.
9. Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R & Aunis D (1993) Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217, 247-257.
10. Mains RE, Zhou A & Parkinson D (1996) The biosynthetic processing and secretion of endogenous carboxypeptidase H in mouse pituitary cells. Ann N Y Acad Sci 805, 10-18.
11. Doblinger A, Becker A, Seidah NG & Laslop A (2003) Proteolytic processing of chromogranin A by the prohormone convertase PC2. Regul Pept 111, 111-116.
12. Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE & O'Connor DT (1996) Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 98, 148-156.
13. Iacangelo AL & Eiden LE (1995) Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regul Pept 58, 65-88.
14. Gadroy P, Stridsberg M, Capon C, Michalski JC, Strub JM, Van Dorsselaer A, Aunis D & Metz-Boutigue MH (1998) Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors. J Biol Chem 273, 34087-34097.
15. Strub JM, Garcia-Sablone P, Lonning K, Taupenot L, Hubert P, Van Dorsselaer A, Aunis D & Metz-Boutigue MH (1995) Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem 229, 356-368.
16. Bauer SH, Zhang XY, Liang F, De Potter WP, Claeys M & Przybylski M (1997) Isolation and identification of intact chromogranin A and two N-terminal processing products, vasostatin I and II, from bovine adrenal medulla chromaffin granules by chromatographic and mass spectrometric methods. Neuropeptides 31, 273-280.
17. Bauer SH, Zhang XY, Van Dongen W, Claeys M & Przybylski M (1999) Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry. Anal Biochem 274, 69-80.
18. Nobels FR, Kwekkeboom DJ, Bouillon R & Lamberts SW (1998) Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest 28, 431-440.
19. Spadaro A, Ajello A, Morace C, Zirilli A, D'Arrigo G, Luigiano C, Martino F, Bene A, Migliorato D, Turiano S, et al. (2005) Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. World J Gastroenterol 11, 1987-1990.
20. Dillen L, Miserez B, Claeys M, Aunis D & De Potter W (1993) Posttranslational processing of proenkephalins and chromogranins/secretogranins. Neurochem Int 22, 315-352.
21. Ghia JE, Crenner F, Metz-Boutigue MH, Aunis D & Angel F (2004) The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in rats. Life Sci 75, 1787-1799.
22. Ghia JE, Crenner F, Metz-Boutigue MH, Aunis D & Angel F (2004) Effects of a chromogranin-derived peptide (CgA 47-66) in the writhing nociceptive response induced by acetic acid in rats. Regul Pept 119, 199-207.
23. Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B, Aunis D & Metz-Boutigue MH (2002) Structural and biological characterization of chromofungin, the antifungal chromogranin A (47-66)-derived peptide. Ann N Y Acad Sci 971, 359-361.
24. Aardal S, Galindo E, Aunis D & Helle KB (1993) Human chromostatin inhibits endothelin-1-induced contractures in human blood vessels. Regul Pept 47, 25-32.
25. Angeletti RH, Aardal S, Serck-Hanssen G, Gee P & Helle KB (1994) Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. Acta Physiol Scand 152, 11-19.
26. Brekke JF, Osol GJ & Helle KB (2002) N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries. Regul Pept 105, 93-100.
27. Corti A, Mannarino C, Mazza R, Angelone T, Longhi R & Tota B (2004) Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart. Gen Comp Endocrinol 136, 217-224.
28. Mandala M, Brekke JF, Serck-Hanssen G, Metz-Boutigue MH & Helle KB (2005) Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery. Regul Pept 124, 73-80.
29. Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, Parrinello G & Corti A (2002) Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 23, 967-974.
30. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, et al. (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115, 1942-1952.
31. Tota B, Imbrogno S, Mannarino C & Mazza R (2004) Vasostatins and negative inotropy in vertebrate hearts. Curr Med Chem 4, 195-201.
32. Tota B, Mazza R, Angelone T, Nullans G, Metz-Boutigue MH, Aunis D & Helle KB (2003) Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart. Regul Pept 114, 123-130.
33. Cerra MC, De Iuri L, Angelone T, Corti A & Tota B (2006) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res Cardiol 101, 43-52.
34. McVicar CM, Cunningham RT, Harriott P, Johnston CF, Buchanan KD & Curry WJ (2001) Analysis of the post-translational processing of chromogranin A in rat neuroendocrine tissue employing an N-terminal site-specific antiserum. J Neuroendocrinol 13, 588-595.
35. Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B, Aunis D & Metz-Boutigue MH (2001) Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J Biol Chem 276, 35875-35882.
36. Higgins DG (1994) CLUSTAL V: multiple alignment of DNA and protein sequences. Methods Mol Biol 25, 307-318.
37. Blom N, Gammeltoft S & Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294, 1351-1362.
38. Zhang X, Dillen L, Bauer SH, Van Dongen W, Liang F, Przybylski M, Esmans E, De Potter WP & Claeys M (1997) Mass spectrometric identification of phosphorylated vasostatin II, a chromogranin A-derived protein fragment (1-113). Biochim Biophys Acta 1343, 287-298.
39. Hansen JE, Lund O, Tolstrup N, Gooley AA, Williams KL & Brunak S (1998) NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconj J 15, 115-130.
40. Kornfeld R & Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54, 631-664.
41. Morelle W, Slomianny MC, Diemer H, Schaeffer C, van Dorsselaer A & Michalski JC (2004) Fragmentation characteristics of permethylated oligosaccharides using a matrix-assisted laser desorption/ionization two-stage time-of-flight (TOF/TOF) tandem mass spectrometer. Rapid Commun Mass Spectrom 18, 2637-2649.
42. Steiner HJ, Weiler R, Ludescher C, Schmid KW & Winkler H (1990) Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem 38, 845-850.
43. 2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney. J Histochem Cytochem 48, 807-819.
44. Miserez B, Annaert W, Dillen L, Aunis D & De Potter W (1992) Chromogranin A processing in sympathetic neurons and release of chromogranin A fragments from sheep spleen. FEBS Lett 314, 122-124.
45. Dietz JR (2005) Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc Res 68, 8-17.
46. McGrath MF, de Bold ML & de Bold AJ (2005) The endocrine function of the heart. Trends Endocrinol Metab 16, 469-477.
47. Muth E, Driscoll WJ, Smalstig A, Goping G & Mueller GP (2004) Proteomic analysis of rat atrial secretory granules: a platform for testable hypotheses. Biochim Biophys Acta 1699, 263-275.
48. Zheng M, Streck RD, Scott RE, Seidah NG & Pintar JE (1994) The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J Neurosci 14, 4656-4673.
49. Eiden LE (1987) Is chromogranin a prohormone? Nature 325, 301.
50. Beinfeld MC (1998) Prohormone and proneuropeptide processing. Recent progress and future challenges. Endocrine 8, 1-5.
51. Kaplan AP, Joseph K & Silverberg M (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109, 195-209.
52. Beaubien G, Schafer MK, Weihe E, Dong W, Chretien M, Seidah NG & Day R (1995) The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res 279, 539-549.
53. Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, Aunis D & Metz-Boutigue MH (2000) Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 275, 10745-10753.
54. Drees BM, Rouse J, Johnson J & Hamilton JW (1991) Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 129, 3381-3387.
55. Hutton JC, Peshavaria M, Johnston CF, Ravazzola M & Orci L (1988) Immunolocalization of betagranin: a chromogranin A-related protein of the pancreatic B-cell. Endocrinology 122, 1014-1020.
56. Goumon Y, Lugardon K, Gadroy P, Strub JM, Welters ID, Stefano GB, Aunis D & Metz-Boutigue MH (2000) Processing of proenkephalin-A in bovine chromaffin cells. Identification of natural derived fragments by N-terminal sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Biol Chem 275, 38355-38362.
57. Jan Danser AH & Saris JJ (2002) Prorenin uptake in the heart: a prerequisite for local angiotensin generation? J Mol Cell Cardiol 34, 1463-1472.
58. Singh RB, Dandekar SP, Elimban V, Gupta SK & Dhalla NS (2004) Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem 263, 241-256.
59. Lodish HF & Kong N (1984) Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex. J Cell Biol 98, 1720-1729.
60. Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, Van Dorsselaer A, Aunis D & Metz-Boutigue MH (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem 271, 28533-28540.
61. Strub JM, Sorokine O, Van Dorsselaer A, Aunis D & Metz-Boutigue MH (1997) Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities. J Biol Chem 272, 11928-11936.
62. Goumon Y, Strub JM, Moniatte M, Nullans G, Poteur L, Hubert P, Van Dorsselaer A, Aunis D & Metz-Boutigue MH (1996) The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem 235, 516-525.
63. Sirimanne SR & May SW (1995) Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition. Biochem J 306 (1), 77-85.
64. Aardal S & Helle KB (1991) Comparative aspects of the endocrine myocardium. Acta Physiol Scand Suppl 599, 31-46.
65. De Bold AJ, Borenstein HB, Veress AT & Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28, 89-94.
66. Corti A, Mannarino C, Mazza R, Colombo B, Longhi R & Tota B (2002) Vasostatins exert negative inotropism in the working heart of the frog. Ann N Y Acad Sci 971, 362-365.
67. Goumon Y, Angelone T, Schoentgen F, Chasserot-Golaz S, Almas B, Fukami MM, Langley K, Welters ID, Tota B, Aunis D, et al. (2004) The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J Biol Chem 279, 13054-13064.